Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 2Phase 1 2Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 2760Carcinoma, Non-Small-Cell Lung 2260Prostatic Neoplasms 1425Colorectal Neoplasms 1290Neoplasms 1258Multiple Myeloma 1084Lung Neoplasms 1048Neoplasm Metastasis 994Leukemia, Myeloid, Acute 984Lymphoma 900Melanoma 862Pancreatic Neoplasms 818Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 753Recurrence 750Leukemia 733Lymphoma, Non-Hodgkin 684Leukemia, Lymphocytic, Chronic, B-Cell 665Lymphoma, Large B-Cell, Diffuse 616Squamous Cell Carcinoma of Head and Neck 615Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 596Brain Neoplasms 592Carcinoma, Renal Cell 586Glioblastoma 572Rectal Neoplasms 563Myelodysplastic Syndromes 522Sarcoma 521Lymphoma, Follicular 516

Interventions

lithium sulfate 1Lithium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Memory Disorders × Clear all
NCT06051240 2024-04-12

LiBRA

Region Stockholm

Phase 2 Recruiting
84 enrolled
CNS

Brain Neoplasms, Memory Disorders, Radiation Injuries, Cognitive Dysfunction

NCT00047476 2005-06-24

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

Celgene

Phase 2 Completed
160 enrolled

Chemotherapy-Related Cognitive Impairment, Fatigue, Memory Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡